Gina Della Porta, left, Director of the Office of Research Affairs, and David Stern, Professor of Pathology and Vice Chair for Basic and Translational Sciences, who oversees the office. In just one year, the Department of Pathology’s Office of Research Affairs has made an impact.
- September 08, 2023
The study's findings suggest that NC318, both alone and in combination with pembrolizumab, improved response rates and clinical outcomes for some patients with NSCLC.
- August 28, 2023
Cancer vaccines utilizing mRNA vaccine technology have such potential that ARPA-H, a newly established White House-originated program, has made it the focus of its first ever grant to be split among teams at Emory University, Yale School of Medicine, and the University of Georgia.
- August 25, 2023
Yale scientists are evaluating a new method to treat debilitating and deadly pulmonary fibrosis.
- August 22, 2023
Stephania Libreros, PhD, a newly appointed Assistant Professor of Pathology and a member of the Vascular Biology Therapeutics Program at Yale School of Medicine, was recently awarded a National Institute of Health (NIH) K99-R00 Award from National Heart Lung and Blood Institute, to support her independent research as she moves into a full-time tenure track faculty position.
- August 15, 2023
Yale Pathology Validates Immunohistochemistry for Quick Assessment of NPM1-Mutated Acute Myeloid Leukemia
Samantha St. Clair, Clinical Technologist in the Immunohistochemistry Lab, was singled out for her work.
- August 10, 2023
Yale Dermatology Clinical Instructor and Postdoctoral Fellow Simon Roy, MD has received a $50,000 Dermatology Fellowship Award from the Melanoma Research Alliance. This competitive grant boosts Dr. Roy's efforts to conduct research into acral melanoma - a rare and understudied melanoma subtype - among a diverse patient population.
- August 03, 2023
Yale Cancer Center researchers have made a significant advance in understanding the mechanisms of resistance to targeted therapies used in the treatment of lung adenocarcinoma driven by EGFR mutations.
- July 27, 2023
A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.
- July 20, 2023
Scientists knew there was a link between aging and cancer but had little understanding of the key features of aging that may translate to cancer risk. A new Yale study explores a “fingerprint” in cells associated with cancer and aging to better understand if researchers can predict who is most susceptible to cancer.